KdT Ventures — Full Portfolio

Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway.

BiotechHealthtechAustin, US

APAnand Parikh(Executive Officer, Director, Promoter)inOMOliver Maddocks(Executive Officer, Director)inChristopher W. Gerry(President and General Counsel)

BoardAMAlex Morgan(Director)inJayson Dallas(Director)Robert Gould(Director)

Co-investorsABAble PartnersAGAgFunderATAtacama VenturesCOCota CapitalFUFuture VenturesISiSelect Fund+7 more

Debut applies AI and biotechnology to discover and formulate cosmetic ingredients and beauty products, decoding skin and hair at the genomic level to create novel actives.

Advanced ManufacturingAI & Machine LearningBiotechConsumerSan Diego, US

Joshua Britton(Founder)inBrady Beauchamp(Founder)Greg Weiss(Founder)

BoardCACain A. McClary(Director)in

Board seatCMCain McClary· per SEC Form D

Co-investorsGSGS FuturesMAMaterial ImpactBRBreakout VenturesSASandbox IndustriesACACVC PartnersBEBetter Ventures Central Llc+12 more

Solugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale.

Advanced ManufacturingBiotechCleantechClimate TechHealthtechHouston, US

SHSean Hunt(CTO, Co-Founder)inGCGaurab Chakrabarti(CEO, Co-Founder)inJTJonathan Tang(Investor)inSSSlava Solonitsyn(Investor)in

BoardSBSeth Bannon(Director)in

Co-investorsFIFifty YearsFOFounders FundLOLowercarbon CapitalY Y CombinatorBABaillie GiffordGIGIC+40 more

Andes develops a microbial technology that converts atmospheric carbon dioxide into stable soil inorganic carbon, enabling agricultural fields to generate verified carbon credits for emissions reductions.

AgTechCleantechClimate TechImpact & Social GoodAlameda, US

Board seatPGPhil Grayeski· per SEC Form D

Co-investorsCACavallo VenturesLELeaps by BayerVOVoyager Partners

Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.

BiotechClimate TechFoodTechNew MaterialsAlameda, US

Scott Franklin(Executive Officer, Director)inCDCharles Dimmler(Executive Officer, Director)inJKJohn Krzywicki(CEO)inLWLayla Ward(CFO)inCLCasey Lippmeier(CTO)inLPLeon Parker(SVP, Molecular Biology)in

Board seatAndrew Cain McClaryCMCain McClary· per SEC Form D

Co-investorsBABaruch Future VenturesBRBreakout VenturesCACavallo VenturesPLPlug and Play VenturesVIViking GlobalBUBuilders VC+5 more

Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium.

BiotechDeep TechSan Francisco, US

Mubhij Ahmad(Executive Officer, Director)David Rabuka(Director)Timothy Paul Day(Director)

BoardDLDrew Lanza(Director)in

Board seatAndrew Cain McClary· per SEC Form D · $8.9M raise · filed Apr 2022

Co-investorsBEBerkeley CatalystBLBlue Bear Ventures

Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.

BiotechDeep TechSan Carlos, US

MHMatthew Hill(Executive Officer, Director)in

BoardPZPeter Zhou(Director)inJonathan Sheena(Director)in

Board seatCMCain McClary· per SEC Form D

Co-investorsACACVC PartnersANAndreessen HorowitzINIn-Q-TelRARaptor GroupTRTriatomic CapitalAMAME Cloud Ventures+1 more

Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases.

BiotechDeep TechBoston, US

WLWayne Lencer(Founder)HGHunter Goble(Founder)inJWJustin Wolfe(Founder)inWilliam Hunter Goble(Executive Officer, Director)Phil Grayeski(Director)

Board seatPGPhil Grayeski· per SEC Form D

Co-investorsPEPear VCPOPortal InnovationsTATau VenturesDIDigitalis VenturesTATAU VenturesXOXora Innovation Pte Ltd

ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.

BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US

HCHarshal Chokhawala(Chief Executive Officer & Co-Founder)inLindy Fishburne(Director)Phil Grayeski(Director)Taehong Huh(Director)Timothy Dummer(Executive Officer, Director)Jon Kuchenreuther(Co-Founder)

Board seatPGPhil Grayeski· per SEC Form D

Co-investorsACAccelr8BRBreakout LabsBRBreakout VenturesCACavallo VenturesDUDudley FundFRFreshTracks Capital+8 more

STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients.

BiotechDeep TechHealthtechLongevityMedical Devices

MLMichael Luther(CEO)in

Co-investorsASAscension VenturesBRBreakout LabsBRBreakout VenturesDEDelos CapitalGAGaingelsNYNYBC Ventures+2 more

54gene is an African genomics company offering research, services, and development focused on including under-represented African genomic data in medical research.

BiotechDeep TechHealthtechWellness & FitnessLagos, NG

GAGatumi Aliyu(Founder)inAEAbasi Ene-Obong(CEO)inOFOgochukwu Francis Osifo(Founder)inDamilola Oni

Co-investorsADAdjuvant CapitalBEBetter Ventures Central LlcBVBVP InvestorsENEndeavor CatalystFIFifty YearsFUFuture Africa+16 more

Abridge builds AI software that converts clinical conversations into structured insights for healthcare providers.

AI & Machine LearningDigital HealthHealthtechPhiladelphia, US

SRShiv Rao(CEO, Co-Founder)inSKSandeep Konam(Founder)inJCJulia Chapin(Founder)Sagar Sanghvi(Executive Officer)inFlorian Metze(Founder)Shivdev Rao(Founder)

Co-investorsALAlpha Square GroupALalphabet angelsANAndreessen HorowitzARArcherman CapitalATAtria VenturesBEBessemer Venture Partners+27 more

Andes is a mission-driven company focused on protecting the planet and applying technology in a nature-related context.

AgTechBiotechClimate Tech

Co-investorsACAccelr8CACapria VenturesCACavallo VenturesGEGermin8 VenturesSUSunna VenturesVOVoyager Partners+3 more

Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance.

AI & Machine LearningBiotechDeep TechAustin, US

Austin Cole(CEO & Founder)Guillaume Cottarel(Head of Program)inRDRussell Durrett(Chief Business Officer)

Co-investorsCICivilization Ventures Management, LlcOMOMX VenturesAXAxial VC

Braid Health combines AI imaging copilots with board-certified radiologists to provide second opinions on MRI, CT, and ultrasound scans, along with AI-generated explanations and workflow tools.

AI & Machine LearningDigital HealthHealthtech

Kevin Quennesson(Founder)in

Co-investorsBRBronze InvestmentsJAJazzya InvestmentsLULux CapitalMYMyelin VCSTStudio ManagementSTStudio Management LLC

Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation.

BiotechDeep Tech

CGCorey Gray(Co-founder and CEO)inMMMichael McKeown(Co-founder and Head of Research)in

Co-investorsILIllumina VenturesUNUndeterred CapitalZAZAKA VC

Canaery develops a nose-computer interface that combines animal olfaction with neurotechnology and AI to detect substances and diagnose diseases.

AI & Machine LearningBiotechDeep TechHardwareMedical Devices

Gabriel(Chief Executive Officer)Peter(Chief Technology Officer)

BoardDmitry(Chief Science Advisor)

Co-investors1515th RockFLFlorida Opportunity FundGOGood News VenturesNYNYU Innovation Venture FundBRBreakout VenturesDODolby Family Ventures

Cavallo Ventures is the venture capital arm of Wilbur-Ellis, investing in innovative technology companies across agriculture, specialty chemicals, and animal nutrition sectors.

AgTechEnterprise Software

MWMichael Wilbur(President)in

Co-investorsWIWilbur-Ellis [Cavallo]ACAccelr8BUBuilders VCGEGermin8 VenturesLELeaps by Bayer

Character Bio is a patient-driven therapeutics company that combines genomics, longitudinal clinical and imaging data, and machine learning to identify genetic drivers of disease progression and develop new treatments, with a focus on polygenic diseases.

AI & Machine LearningBiotechDigital HealthJersey City, US

CZCheng Zhang(CEO, Co-Founder)inMarcel van der Brug(Scientific Advisor, Co-Founder)inNick Johnson(Technology Advisor, Co-Founder)inDEDaniel Elgort(Chief Data and Analytics Officer)inLCLaura Carter(Chief Scientific Officer)inRobert Kim(Chief Medical Officer)in

Co-investorsAMaMoonLULuma GroupSASanofi VenturesINInnovation EndeavorsCACantos VenturesCACatalio Capital Management, LP+5 more

Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates.

Biotech

ZJZahra Jawad(Founder)in

Co-investorsBLBlueYard CapitalPAPace VenturesZAZAKA VC

Dimension Bio is a biotechnology company developing regenerative therapeutics using its BioNidum platform, which combines materials science, 3D printing, and digital manufacturing to produce implantable and injectable biosynthetic scaffolds that promote tissue healing.

BiotechHealthtechMedical DevicesNew MaterialsChicago, US

CNCaralynn Nowinski Collens(Co-founder & CEO)inRSRamille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Co-founder & CSO)AJAdam Jakus(Co-Founder)inRamille S.(Founder)inLarry Weinstein(SVP, Manufacturing & Quality Operations)

Co-investorsALAlumni VenturesBEBetter Ventures Central LlcGAGaingelsHAHarvard Business Angels of ChicagoHAHAWKTAILLOLofty Ventures+5 more

Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases.

AI & Machine LearningBiotechWatertown, US

EKEric Kelsic(Founder)inSSSam Sinai(Founder)inAVAdrian Veres(Founder)inGCGeorge Church(Scientific Cofounder, SAB)inTBTomas Bjorklund(Scientific Co-founder, SAB)inACAlan Crane(Founder)in

Co-investorsANAndreessen HorowitzCRCRV (Charles River Ventures)GEGENERAL INCEPTIONGVGV (Google Ventures)LULux CapitalOBObvious Ventures+2 more

Elemental Machines provides an IoT platform combining hardware, software, and data science to monitor lab and manufacturing equipment, environments, and workflows in real time.

AI & Machine LearningBiotechHardwareHealthtechIoTSaaSCambridge, US

SISridhar Iyengar(Executive Officer, Director)inUna Ryan(Director)JKJeff Klemens(Director)inSVSonny Vu(Director)in

BoardGTGaurav Tewari(Director)inRDRobert Davoli(Director)in

Co-investorsGUGutbrain VenturesHEHemisphere Ventures LLCJOJoint EffectsOMOmega Venture PartnersRORock Health CapitalSASageview Capital+4 more

Sridhar Iyengar(Founder)

Co-investorsHEHealthtech CapitalDIDigitalis VenturesGUGutbrain Ventures

Elo develops plant-based food ingredients and technologies to enhance nutritional value, taste, and climate resilience in everyday foods.

AgTechBiotechClimate TechFoodTechNew MaterialsDurham, US

ToddMFMichele Fite(Executive Officer)inMTMatthew Todd Rands(Executive Officer, Director)CPChloe Pavely(Executive Officer)inMDMatt DiLeo(Director)inPBPaul Boyer(Executive Officer)in

Co-investorsDCDCVC (Data Collective)ACAccelr8DCDCVC BioNONovo Holdings

Epana Bio develops therapies for autoimmune diseases by leveraging genomics and AI to identify and target cellular origins of disease, with a focus on precision medicine for patient populations.

AI & Machine LearningBiotechDigital Health

Co-investorsBRBreakout LabsBRBreakout VenturesHAHAWKTAILHUHummingbird VenturesOMOMX VenturesPOPoint Financial Capital+2 more

Equii makes food products that combine complete protein with carbohydrates while reducing sugar, positioned around balanced nutrition.

ConsumerFoodTechWellness & Fitness

MBMonica Bhatia(Founder)in

Co-investorsAUAurum Venture PartnersGRGreat Circle VenturesVUVU Venture PartnersWEWestern Technology Investment

Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them.

BiotechHealthtechSan Diego, US

Rich Stoner(Founder)inDan Knudsen(Founder)Kevin Cooksy(Founder)in

Co-investorsHAHAWKTAILPHPhase Two Ventures

General Sense develops detection technology that augments trained detection animals, aiming to identify molecular threats such as narcotics, crop diseases, human diseases, and bioweapons.

BiotechDeep TechDefense TechHardware

Peter Ledochowitsch(CTO & Co-Founder)inWDWestley Dang(CEO)in

Co-investors1515th RockBRBreakout VenturesDODolby Family VenturesDRDraper AssociatesJUJuniperSOSOSV

Index Biosystems builds an AI platform for food safety and quality assurance (FSQA) teams in food manufacturing, combining AI agents that automate investigations and audit prep with BioTags — food-grade, DNA-labeled microbial tracers that generate molecular data for tracing material movement and validating sanitation.

AI & Machine LearningBiotechFoodTechToronto, CA

MBMike BorginDavid Singerin

Co-investorsUNUndeterred CapitalVAVanedge CapitalVAVanedge Capital Limited Partnership

Leeta Materials manufactures high-performance industrial materials using advanced data science and a proprietary platform to enable customizable material formulations.

Advanced ManufacturingDeep TechNew MaterialsGoleta, US

Linus Kautzsch(Executive Officer, Director)Kira Wyckoff(Executive Officer, Director)

BoardSSSarah Sclarsic(Director)in

Co-investorsVOVoyager Partners

MacroCycle uses a proprietary chemical process called SolvoGenesis, based on solvent systems and macrocyclic chemistry, to convert textile waste into pure polyester resin at low cost.

Circular EconomyCleantechNew MaterialsCambridge, US

Stwart Peña Feliz(Executive Officer, Director)inJRJan-Georg Rosenboom(Executive Officer, Director)in

BoardCatia Cesari(Director)TFTemple Fennell(Director)in

Co-investorsCICircular Innovation FundCOCollaborative FundNENeotribe VenturesVOVolta CircleCLClean Energy VentureCLClean Energy Ventures+2 more

March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.

BiotechMedical DevicesHouston, US

SHSarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)MBMalcolm Brenner(Co-founder)

BoardTLThomas Luby(Director)inPOPeter Olagunju(Director)inJoseph Petrosino(Director)

Co-investorsMIMission Biocapital4B4BIO CapitalCACancer FocusCACancer FundFIFitz Gate VenturesMOModi Ventures+2 more

Marigold Health operates an anonymous online community and app where people facing mental health or substance use challenges support each other, with some members receiving one-on-one help from certified Peer Recovery Coaches.

AI & Machine LearningDigital HealthMental Health

SJShrenik Jain(Founder)in

Co-investorsABAbell Foundation, Inc.BABantam GroupDODorm RoomEPEpsilon Health InvestorsFLFlare Capital PartnersRORock Health Capital+6 more

Modulus Therapeutics was a Seattle biotech spun out of the Allen Institute for AI that used machine learning to engineer immune cells, initially NK cells for cancer, later shifting toward autoimmune cell therapies.

BiotechSeattle, US

Bryce R Daines(Executive Officer, Director)Max C Darnell(Executive Officer, Director)

Co-investorsMAMadrona Venture Group

Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs.

AI & Machine LearningBiotechCrypto & Web3

Paul Kohlhaas(Founder)inNeeta Singal(Founder)Saurabh Singal(Founder)Saurabh Singal Neeta Singal(Founder)Tyler Golato(Founder)VWVincent Weisser(Founder)in

Co-investors1K1k(x)1K1kxAMAmino CollectiveATAtria VenturesBABackedBOBoxGroup+17 more

Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's.

AI & Machine LearningBiotechDeep TechSan Francisco, US

KSKevan Shokat(Co-Scientific Founder & Chairman of the SAB)TSThomas Südhof(Co-Scientific Founder & SAB Member)Seth Stratton(Director)Dirk Langdorf(Director)Nicholas Hertz(Executive Officer, Director)

Co-investorsBEBEVCDODolby Family VenturesSVSV Health InvestorsTWTwo Bear CapitalDEDementia Discovery Fund

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

SSSameer Sheth(Founder)inSSSunil Sheth(Founder)NHNick Halper(Chief Operating Officer)inSGSteve Goetz(Chief Technology Officer)inAAAnthony Arnold(Director)inKaiyuan Yang(Founder)

Co-investorsARArboretum VenturesDIDivergent CapitalDODolby Family VenturesFEFeatures Capital HoldingsPSPsyMed VenturesTMTMC Venture Fund+6 more

Nosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development.

AI & Machine LearningBiotechDeep TechMedical Devices

SMSeth Myers(Founder)in

Co-investorsALAlleyCorpMAMadrona Venture GroupALAlley Robotics Ventures

Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making.

AI & Machine LearningBiotechDigital HealthSan Carlos, US

ANAkshay Nanduri(Founder)inSalmaan Ahmed(Executive Officer)Jonathan Fleming(Director)

Co-investors51515 VenturesBLBlue Venture FundsLILifeX VenturesDIDigitalis Ventures

AI-powered pathology for improved patient outcomes

Boston, US

ABANDREW BECK(Executive Officer, Director)inAKADITYA KHOSLA(Executive Officer, Director)Aditya Khosla(Founder)Andy Beck(Chief Executive Officer, Co-founder)

BoardMICHELLE DIPP(Director)SLSTANLEY LAPIDUS(Director)in

Co-investors8V8VCBIBIOSPRING PARTNERSFAFairhaven Capital PartnersGEGeneral AtlanticGEGeneral CatalystHIHighsage Ventures+7 more

Perceptive applies AI and robotics technology to dental practice, helping dentists increase patient capacity.

AI & Machine LearningHealthtechMedical DevicesRoboticsBoston, US

CCChris Ciriello(Founder)inSPScott Phillips(Founder)inPGPhil Getto(CTO)inAFAlex Furleigh(COS)inPhillip Getto(CEO)James Jackson(Vice President Engineering)

Co-investorsANAngel Physicians FundC3C3 VenturesDIDIANENecessary VenturesRERevere PartnersTSTSVC+10 more

PHNX Materials refines industrial waste and byproduct streams into critical metals such as gallium, germanium, and silicon, along with products for the building materials and agriculture industries.

Circular EconomyCleantechNew Materials

KMKrish Mehta(Cofounder)in

Co-investorsDIDivergent CapitalRARavelin CapitalSTStartX

Radar Therapeutics develops precision-expressed mRNA-based therapeutics using its RADAR platform, which reads a cell's RNA profile in real time to activate genetic payloads only in targeted cells and avoid effects in non-target cells.

AI & Machine LearningBiotechDeep Tech

Co-investorsBEBEVCNFNFXPIPioneerSTStartXTHThe 23 Fund

Rarebird produces specialty coffee containing paraxanthine (Px), a metabolite of caffeine that delivers energy and focus with fewer side effects than traditional caffeine.

ConsumerDirect to ConsumerFoodTechHealthtechWellness & FitnessSan Francisco, US

JDJeffrey Dietrich(Founder)inAnn Dunn Andracchio(Director)Dr. Jeffrey Dietrich(Founder)

Co-investorsFIFirst Round CapitalFUFundersClubJUJude GomilaSOSoma CapitalY Y CombinatorAGAgFunder+3 more

Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.

BiotechHealthtechLongevitySan Diego, US

NDNoah Davidsohn(CSO, Co-Founder)inDODaniel Oliver(CEO, Co-Founder)inGCGeorge Church(Co-Founder and SAB)DADeborah Ascheim(Chief Medical Officer)in

BoardDZDavid Zhu(Director)in

Co-investorsCOCompanion FundCOConnecticut InnovationsDIDigitalis VenturesGAGaingelsKEKendall Capital PartnersLILifespan Vision Ventures+1 more

Remedy Robotics develops a robotic telesurgery approach for treating stroke and other cardiovascular conditions remotely, aiming to raise the standard of care across the cardiovascular continuum.

AI & Machine LearningHealthtechMedical DevicesRoboticsSan Francisco, US

David Bell(Founder)Jake Sganga(Founder)

Co-investorsDCDCVC (Data Collective)7P7percent VenturesBLBlackbird VenturesDIDivergent CapitalPAPathbreaker Ventures

Revel Pharmaceuticals develops enzyme-based therapeutics designed to recognize and reverse molecular damage that accumulates in the body's structural tissue — collagen, elastin, and extracellular matrix — targeting age-related damage that drives disease.

BiotechDeep TechLongevitySan Francisco, US

ACAaron Cravens(Co-Founder & CEO)inJCJennifer Cochran(Director)

Co-investorsGAGaingelsLOLong Game

Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds.

BiotechHealthtech

Co-investorsAMAmplitude Venture CapitalFIFinchley Healthcare VenturesINInBC Investment Corp.THThin Air Labs

Sepsis Scout (formerly Patchd Medical) developed technology for sepsis detection, applying machine learning to physiological measurements in the medical device space.

AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Francisco, US

RQRobert Quinn(CEO)inWTWei-Jien Tan(CTO)in

Co-investorsY Y CombinatorABAbenteuer.VenturesANAnthemis VentureBVBVM FundGAGaingelsKAKapor Capital+4 more

BiotechWaltham, US

Ellen E. Sheets(Executive Officer, Director)in

BoardCarl M. Berke(Director)inNancy Hong(Director)in

Co-investorsBOBold Capital PartnersDIDigitalis VenturesRIRiverVest Venture Partners

Skeletalis is developing OASIS, a targeted small-molecule platform for musculoskeletal and bone health that concentrates therapy at sites of active bone loss while preserving the body's natural bone remodeling.

BiotechDeep TechHealthtech

Co-investorsAGage1PIPillar VC

GCGaurab Chakrabarti(Founder)inSHSean Hunt(Founder)in

Co-investorsAEAera VCARArray Ventures Management LlcBOBoxGroupBUBuckley Ventures Management Company LlcCACarbon DirectFIFifty Years+9 more

SURGE develops clinical approaches for cancer immunotherapy and post-surgical cancer recurrence prevention.

BiotechHealthtechMedical Devices

Michael Goldberg(CEO)in

Co-investorsALAlumni VenturesINIntuitive Ventures

Syenex provides cell delivery technologies and contract development services for therapeutic cell engineering, serving biopharmaceutical companies developing cell-based therapies.

BiotechDeep TechMedical DevicesEvanston, US

John D. Rosanelli(Executive Officer, Director)

Co-investorsALAlleyCorpLILightbankALAlley Robotics Ventures

Synteny develops an AI platform that models the rules of molecular recognition to design modular protein therapeutics, pairing generative biology models with high-throughput experimental validation.

AI & Machine LearningBiotechDeep TechLondon, GB

JBJamie Blundell(Co-Founder & CSO)inLilly Sophia Wollman(Co-Founder & CEO)

Co-investorsALAlumni VenturesHAHAWKTAILINIn-Q-TelPIPICUS CAPITALSQSquareOne

Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes.

BiotechDeep TechHealthtechSan Francisco, US

Co-investorsCICivilization Ventures Management, LlcEIEisai Innovation, Inc.LALaurier Startup FundMIMichigan Capital NetworkMIMitsui Global Investment

Durham, US

Kris Wood(Director)inEoin McDonnell(Executive Officer, Director)in

Co-investorsALAlexandria

Terray is a drug discovery company that combines proprietary hardware, large-scale experimental datasets, and AI through its EMMI platform to design small molecule medicines.

AI & Machine LearningBiotechDeep TechPasadena, US

EBEli Berlin(Founder)inJacob Berlin, Ph.D.(Chief Executive Officer)Jacob Berlin(Founder)Jacob Berlin Eli Berlin(Founder)Nathan Collins(Founder)

BoardCPChris Picardoin

Co-investorsDEDeviation CapitalDIDigitalis VenturesGAGaingelsMAMadrona Venture GroupMAMana VenturesNVNVIDIA+7 more

Theator builds an intelligence layer for surgery that turns video from minimally invasive procedures into usable data.

AI & Machine LearningDigital HealthHealthtechMedical DevicesPalo Alto, US

Dotan Asslemann(Director)TWTamir Wolf(Executive Officer, Director)inDADotan Asselmann(Founder)in

BoardGLGigi Levy Weiss(Director)in

Co-investorsBLBlumberg CapitalICICON - Israel Collaboration NetworkINInsight PartnersNFNFXSTStageOne VenturesIAiAngels+2 more

Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.

Biotech

Co-investorsBEBeresford VenturesCRCreative VenturesFIFifty YearsFRFREEFLOWINIn-Q-TelMAMaterial Impact+2 more

Unravel Bio uses computational drug discovery and advanced animal models to accelerate pharmaceutical development with lower cost and risk.

AI & Machine LearningBiotechDeep TechDigital HealthBoston, US

RNRichard Novak(CEO & Co-Founder)inFrederic Vigneault(CSO & Co-Founder)inDIDonald Ingber(Director)inLewis Geffen(Executive Officer)

Co-investorsBABacchus Venture CapitalBEBeresford VenturesICIcebook Investments Corp.SLSlingshot VenturesACActive PartnersBOBoxOne Ventures+1 more

Xilis, Inc. was a company that developed micro-organosphere (MOS) technology for laboratory use; the company has closed and its MOS technology is now sold by Uniform Bio as the MOSgen benchtop instrument.

BiotechHardwareHealthtech

Co-investorsDUDuke Capital PartnersFPFPV

Zag Bio develops thymus-targeted bifunctional antibodies designed to induce central tolerance for treating autoimmune diseases.

BiotechDeep TechHealthtechMedical DevicesCambridge, US

Alan Crane(Founder)Diane Mathis(Founder)Joanne Lim(Co-founder)Dr. Diane Mathis(Founder)Jo Viney(Founder)John Kulman(Founder)

Co-investorsLILightspeed Venture PartnersMIMission BiocapitalPEPear VCSASanofi VenturesPOPolaris PartnersTHThe Engine Ventures